Showing results (81-90 of 190) with videos related to

Sort By:
Pageof 19
Plos One|April 25, 2013
Role of alveolar β2-adrenergic receptors on lung fluid clearance and exercise ventilation in healthy humansStefania Paolillo, Riccardo Pellegrino, Elisabetta Salvioni, et al.
Rheumatology International|April 12, 2018
The Egyptian Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Yasser El Miedany, Dalia M E El Mikkawy, Sally S Youssef, et al.
The Journal of Rheumatology|June 17, 2014
Female sex and oligoarthritis category are not risk factors for uveitis in Italian children with juvenile idiopathic arthritisSerena Calandra, Maria Chiara Gallo, Alessandro Consolaro, et al.
Journal of Clinical Medicine|August 7, 2021
Oral Antioxidant Treatment of Men Significantly Improves the Reproductive Outcome of IVF CyclesPaola Scaruffi, Emanuele Licata, Elena Maccarini, et al.
Arthritis Care & Research|July 2, 2014
Defining criteria for disease activity states in nonsystemic juvenile idiopathic arthritis based on a three-variable juvenile arthritis disease activity scoreAlessandro Consolaro, Giorgia Negro, Maria Chiara Gallo, et al.
Orphanet Journal of Rare Diseases|October 14, 2021
Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysisGiorgia Coratti, Costanza Cutrona, Maria Carmela Pera, et al.
European Stroke Journal|August 29, 2023
Effect of an educational intervention to increase stroke awareness among Italian high school students: A prospective study in TuscanyAntonio Di Carlo, Marzia Baldereschi, Francesca Bovis, et al.
Plos One|October 15, 2020
Viremia copy-years and risk of estimated glomerular filtration rate reduction in adults living with perinatal HIV infectionGiovanni Sarteschi, Antonio Di Biagio, Emanuele Focà, et al.
Frontiers in Immunology|March 21, 2020
Wide Cytokine Analysis in Cerebrospinal Fluid at Diagnosis Identified CCL-3 as a Possible Prognostic Factor for Multiple SclerosisMarco Puthenparampil, Erica Stropparo, Sofia Zywicki, et al.
Nature Communications|September 26, 2022
Estimating individual treatment effect on disability progression in multiple sclerosis using deep learningJean-Pierre R Falet, Joshua Durso-Finley, Brennan Nichyporuk, et al.
Pageof 19